Skip to main content

Table 1 Demographic and clinical features of the recruited SCA3 patients

From: Abnormal eye movements in spinocerebellar ataxia type 3

Variable

Cross-sectional study

 

(n = 74)

Sex (male,%)

39 (52.7%)

Mean age (years)

45.04 ± 11.97

Age of onset (years)

38.79 ± 12.53

Disease duration (years)

6.25 ± 6.24

Educational year

10.53 ± 4.52

BMI

23.69 ± 21.46

Hyperreflexia (%)

33 (44.6%)

Vision loss

24 (32.4%)

ICARS-I

12.27 ± 6.71

ICARS-II

15.69 ± 8.97

ICARS-III

1.95 ± 1.53

ICARS-IV

2.24 ± 1.40

Total ICARS score

32.15 ± 16.31

SARA score

11.01 ± 5.73

MoCA score

23.58 ± 4.68

HDRS-24 score

8.80 ± 8.92

HARS score

6.82 ± 7.04

ESS score

5.41 ± 4.67

PSQI score

7.23 ± 4.46

CAG repeat length

66.07 ± 11.15

  1. SCA3 spinocerebellar ataxia 3; BMI body mass index; ICARS International Cooperative Ataxia Rating Scale; SARA Scale for the Assessment and Rating of Ataxia; MoCA, Montreal Cognitive Assessment; HDRS-24 Hamilton Depression Scale; HARS Hamilton Anxiety Scale; ESS Epworth Sleepiness Scale; PSQI Pittsburgh sleep quality index